Study track definition

Study track means the procedure for evaluating an application that includes a scoping meeting, system impact study, and facilities study.
Sample 1Sample 2Sample 3
Study track means the procedure for evaluating a proposed interconnection that is ineligible for, or did not pass, the fast track, and which includes, at a minimum, a scoping meeting, a system impact study, and a facilities study.
Sample 1Sample 2Sample 3
Study track means the procedure used for evaluating a proposed interconnection as described in R 460.952 to R 460.962.
Sample 1Sample 2

Examples of Study track in a sentence

  • Fast track supplemental review fee Study track application and fee System impact study agreement and fees Facilities study agreement and fees Interconnection operating agreement (3) The commission shall provide a 60-day period for comment before approving the applications for interconnection procedures.

  • The scorecard on the next page provides a snapshot of the overall performance as at the end of FQ3 2019-20.

  • The data in the table overleaf gives an interim position with some of the indicators using carry-over data from the previous FQ3 position.

  • The performance for Finance Quarter 1 (FQ1) 2019-20 was reported to the IJB in September 2019, performance for FQ2 2019-20 was reported to the IJB in January 2019 and performance for FQ3 2019-20 was reported to the IJB in March 2020.

  • The HSCP has received £377,800 in 2019/20 to support this activity with 60% of the funding released in the first tranche and the balance to be released if waiting times performance trajectories are met.A comparison between the FQ3 position and the AOP figures across all consultant outpatient specialties reporting variances against the 12 week target is detailed below: 12 week target: 333 New Outpatient Appointments at Consultant Led Clinic breaches as at Q3 19/20.

  • Service Redesign has been implemented during the latter part of FQ3 resulting in changes to the management arrangements of the area teams.

  • This paper presents the Environment, Development and Infrastructure Committee with Development and Economic Growth Service and Roads and Infrastructure Services performance report with associated scorecard for performance in FQ3 2019-20 (October 2019 to December 2019).

  • Study track: The procedure used for evaluating a proposed interconnection utilizing a system impact study and facilities study.

  • Sickness absence has reduced to 2.61 days sickness absence per employee in FQ3 and is now within the target of 2.98 days sickness absence per employee.

  • In FQ3 98.6% 3 of applications were responded to within 20 days compared to 96.1% in FQ2.


More Definitions of Study track

Study track means the procedure for evaluating an application that
Sample 1

Related to Study track

  • Study Centre means a centre established and maintained or recognized by the University for the purpose of advising, counselling or for rendering any other assistance required by the students in the context of distance education;

  • Development Phase means the period before a vehicle type is type approved.

  • Study Subject an individual who participates in the Study, either as a recipient of the Investigational Product (defined below) or as a control. Subjekt studie: jednotlivec, který se účastní Studie, buď jakožto příjemce Hodnoceného léčiva (ve smyslu níže uvedené definice) nebo jako kontrolní subjekt.

  • Phase 3 Study means a clinical study of an investigational product in patients that incorporates accepted endpoints for confirmation of statistical significance of efficacy and safety with the aim to obtain Regulatory Approval in any country as described in 21 C.F.R. 312.21(c), or a comparable Clinical Study prescribed by the relevant Regulatory Authority in a country other than the United States. The investigational product can be administered to patients as a single agent or in combination with other investigational or marketed agents [***]

  • Development Program means the implementation of the development plan.

  • Study Site means the location(s) under the control of the Institution where the Study is actually conducted as set out in Schedule 1.

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.

  • Study means the investigation to be conducted in accordance with the Protocol.

  • scientific research means any activity in the field of natural or applied science for the extension of knowledge;

  • Phase 1 Clinical Trial means a Clinical Trial of a Product on sufficient numbers of normal volunteers and/or patients that is designed to establish that such Product is safe for its intended use and to support its continued testing in Phase 2 Clinical Trials. For purposes of this Agreement, ‘initiation’ of a Phase 1 Clinical Trial for a Product means the first dosing of such Product in a human subject in a Phase 1 Clinical Trial.

  • Phase IIb Clinical Trial means a clinical trial of a Product on sufficient numbers of patients that is designed to provide a preliminary determination of safety and efficacy of such Product in the target patient population over a range of doses and dose regimens.

  • Phase I Study means a study in humans which provides for the first introduction into humans of a product, conducted in healthy volunteers or patients to obtain information on product safety, tolerability, pharmacological activity or pharmacokinetics, as more fully defined in 21 C.F.R. § 312.21(a) (or the non-United States equivalent thereof).

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Phase I Clinical Study means, as to a particular Licensed Product, an initial clinical study in humans with the purpose of assessing the Licensed Product’s safety, tolerability, toxicity, pharmacokinetics or other pharmacological properties.

  • Clinical Trials means a controlled study in humans of the safety or efficacy of a Product, and includes, without limitation, such clinical trials as are designed to support expanded labeling or to satisfy the requirements of an Agency in connection with any Product Approval and any other human study used in research and Development of a Product.

  • Phase I Clinical Trial means a study in humans which provides for the first introduction into humans of a product, conducted in normal volunteers or patients to generate information on product safety, tolerability, pharmacological activity or pharmacokinetics, or otherwise consistent with the requirements of U.S. 21 C.F.R. §312.21(a) or its foreign equivalents.

  • Phase 4 Clinical Trial means a Clinical Study in any country which is conducted after Regulatory Approval of a product has been obtained from an appropriate Regulatory Authority, consisting of trials conducted voluntarily for enhancing marketing or scientific knowledge of an approved indication and trials conducted due to request or requirement of a Regulatory Authority.

  • Development Works means the external development works and internal development works on immovable property;

  • Study Data shall have the meaning set forth in Section 8.1.

  • Phase II Clinical Study means a human clinical study of a product initiated to determine the safety and efficacy in the target patient population, as described 21 C.F.R. 312.21(b).

  • clinical investigation means any systematic investigation in one or more human subjects, undertaken to assess the safety or performance of a device;

  • Bioassay means the determination of kinds, quantities or concentrations and, in some cases, the locations of radioactive material in the human body, whether by direct measurement, in vivo counting, or by analysis and evaluation of materials excreted or removed from the human body. For purposes of these rules, “radiobioassay” is an equivalent term.

  • Clinical Studies means Xxxxx 0, Xxxxx 0, Xxxxx 0, Xxxxx 3, and such other tests and studies in human subjects that are required by Applicable Law, or otherwise recommended by the Regulatory Authorities, to obtain or maintain Regulatory Approvals for a Licensed Product for one (1) or more indications, including tests or studies that are intended to expand the Product Labeling for such Licensed Product with respect to such indication.

  • Development Site means any parcel or lot on which exists or which is intended for building development other than the following:

  • Biomarker means a parameter or characteristic in a patient or Patient Sample, the measurement of which is useful (a) for purposes of selecting appropriate therapies or patient populations or monitoring disease susceptibility, severity or state, or monitoring therapies for such patient and/or (b) for predicting the outcome of a particular treatment of such patient.

  • Clinical means having a significant relationship, whether real or potential, direct or indirect, to the actual rendering or outcome of dental care, the practice of dentistry, or the quality of dental care being rendered to a patient;